Harmful Algal Bloom and Hypoxia Research and Control Amendments Act of 2025 This bill extends through FY2030 and modifies the Harmful Algal Bloom and Hypoxia Research and Control Act to address algal blooms and hypoxia (deficiency of oxygen) in U.S. marine, estuarine, and freshwater systems. Harmful algal blooms are high concentrations of algae that may create nuisance or toxic conditions that are harmful to humans, animals, aquatic ecosystems, and the economy. The bill directs the Inter-Agency Task Force on Harmful Algal Blooms and Hypoxia to submit to Congress an action strategy for harmful algal blooms at least once every five years. The bill also expands the task force's membership to include the Department of Energy. The bill also expands the duties of the National Oceanic and Atmospheric Administration (NOAA) under the National Harmful Algal Bloom and Hypoxia program. NOAA must also carry out a variety of activities related to monitoring, predicting, preventing, mitigating, and responding to marine, coastal, and Great Lakes harmful algal bloom and hypoxia events. For example, NOAA must establish (1) a national network of observing systems for monitoring, detecting, and forecasting harmful algal blooms; and (2) a national-level incubator program to increase the number of strategies, technologies, and measures available to prevent, mitigate, and control harmful algal blooms. Additionally, the Environmental Protection Agency must develop and enhance operational freshwater harmful algal bloom monitoring, observing, and forecasting programs in lakes, rivers, and reservoirs and carry out other activities related to researching freshwater harmful algal blooms and hypoxia events.
Referred to the Committee on Science, Space, and Technology, and in addition to the Committee on Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Bill introduced
Lobbying filed by MEDICATION ASSISTED TREATMENT LEADERSHIP COUNCIL
Referred to the Committee on Science, Space, and Technology, and in addition to the Committee on Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
| Registrant | Client | Amount | Filed | Period | Issues |
|---|---|---|---|---|---|
| FEDERAL HEALTH POLICY STRATEGIES | MEDICATION ASSISTED TREATMENT LEADERSHIP COUNCIL | $50.0K | Apr 18, 2025 | 2025Q1 | HCR |
The lobbying table lists Senate LDA quarterly reports (LD-2) that cite this bill by number and cover a quarter of the 119th Congress. An LD-2 names a bill as “H.R. 1234” with no Congress, so a report on another Congress, which can only concern a different bill with the same number, is left out, even when it was filed after this Congress began. The amount is what the registrant reported for the whole filing, across every issue on it, not spending on this bill. Official actions and the bill summary come from Congress.gov, and votes from the roll-call record. This page no longer pairs the bill with members' stock trades: matching lobbying clients to traded companies by name, and trades to a bill by date, is not something the records establish.